Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA (DGWPF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dgwpf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Drägerwerk AG & Co. KGaA (DGWPF) measures how much investors pay for each dollar of the company's trailing earnings. DGWPF's current PE ratio of 11.00x is calculated by dividing its stock price of $72.00 by its TTM earnings per share of $8.16. +47.8% elevated vs 5Y avg 7.4x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%10.4x
MedianQ3 · 75%32.5x
Max
At 11.00x, DGWPF's current P/E is within its average historical range over the past 19 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Drägerwerk AG & Co. KGaAYou DGWPF | $1.4B | 11.00x | -68.7% | $8.16 |
 Adcock Ingram Holdings Limited AIHLF | $624M | 7.40x | -79.0% | $5.85 |
 Biotage AB (publ) BITGF | $1.2B | 46.23x | +31.4% | $3.55 |
 Biotest AG BTTAY | $943M | 66.05x | +87.8% | $0.35 |
 CompuGroup Medical SE & Co. KGaA CMPUY | $1.2B | 33.34x | -5.2% | $0.67 |
 CompuGroup Medical SE & Co. KGaA CMPVF | $1.7B | 52.49x | +49.2% | $0.55 |
 China Shineway Pharmaceutical Group Limited CSWYF | $816M | 5.56x | -84.2% | $1.26 |
Industry Average 6 peers with valid PE | — | 35.18x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 8.23x | $7.44 | +25.5% | |
2024-12-31 FY2024 | 6.56x | $6.63 | -16.3% | |
2023-12-31 FY2023 | 7.84x | $5.89 | — | |
2022-12-31 FY2022 | — | $-3.44 | — | |
2021-12-31 FY2021 | 7.12x | $8.22 | -4.7% | |
2020-12-31 FY2020 | 7.46x | $7.70 | -64.1% | |
2019-12-31 FY2019 | 20.78x | $1.88 | -1.9% | |
2018-12-31 FY2018 | 21.19x | $1.93 | +103.6% | |
2017-12-31 FY2017 | 10.40x | $5.54 | -26.0% | |
2016-12-31 FY2016 | 14.05x | $4.62 | -56.7% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Drägerwerk AG & Co. KGaA (DGWPF) measures how much investors pay for each dollar of the company's trailing earnings. DGWPF's current PE ratio of 11.00x is calculated by dividing its stock price of $72.00 by its TTM earnings per share of $8.16.
Frequently asked questions
DGWPF pe ratio · 6 questionsDGWPF's current PE ratio is 11.00x as of 2026-06-08, based on a stock price of $72.00 and TTM EPS of $8.16. Data sourced from Financial Modeling Prep via DGWPF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Drägerwerk AG & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08